Cyta Therapeutics
PrivateLast Round
Accelerator
Sep 5, 2023
Company Overview
Cyta Therapeutics operates in Healthcare & Life Sciences and is based in Lowell, Massachusetts. Its latest recorded funding round was an Accelerator round in September 2023.
Cyta Therapeutics is a biotechnology company developing proprietary polymer-based nanogel delivery systems for the treatment of obesity and cardiometabolic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyta Therapeutics Comparables
Compare Cyta Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hepagene Therapeutics | 78% | |
| Aligos Therapeutics | 77% | |
| Ascletis Pharma Inc. | 77% |
For institutional investors. Book with your work email.
Cyta Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Sep 5, 2023 | ||||
| Grant | Feb 11, 2022 |
For institutional investors. Book with your work email.
Cyta Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Innovation Space | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 52% MoM.
- Feb 11, 2022
Received grant funding to support operations.
For institutional investors. Book with your work email.
Cyta Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cyta Therapeutics's valuation, stock price, and market status.
Is Cyta Therapeutics a public or private company?
Cyta Therapeutics is a private company.
What is the current stock price of Cyta Therapeutics?
Cyta Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cyta Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cyta Therapeutics worth (valuation)?
Valuation information for Cyta Therapeutics is not publicly available.
Can I buy Cyta Therapeutics stock?
Cyta Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cyta Therapeutics's last funding round?
Cyta Therapeutics's most recent funding round was Accelerator on September 5, 2023.
Who are the main investors in Cyta Therapeutics?
Key investors in Cyta Therapeutics include The Innovation Space.
Will Cyta Therapeutics IPO soon?
No public IPO plans have been announced for Cyta Therapeutics.
How can I track Cyta Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cyta Therapeutics's shares on secondary markets.